Lipid Lowering Drugs and Coronary Heart Disease
- 1 January 1975
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 10 (3), 218-225
- https://doi.org/10.2165/00003495-197510030-00004
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Prevention of heart disease by control of risk factors: The time has come to face the factsThe American Journal of Cardiology, 1975
- Mortality from cardiovascular disease.1974
- A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress.1973
- EFFECT OF CHOLESTEROL-LOWERING DIET ON MORTALITY FROM CORONARY HEART-DISEASE AND OTHER CAUSES: A Twelve-year Clinical Trial in Men and WomenThe Lancet, 1972
- Clofibrate in coronary heart disease. Effect on morbidity and mortality.1972
- Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region.1971
- Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.1971
- Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.1971
- Effect of clofibrate on low-density lipoprotein turnover in essential hypercholesterolaemiaJournal of Atherosclerosis Research, 1969
- Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries.1966